Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Central Phamaceutical Joint Stock Company No3 (HNX: DP3)

67,300

-100 (-0.15%)
04/25/2024 12:01

Open67,400

High67,400

Low67,000

Vol1,573

Market Cap.1,446.95

Remain Bid4,727

Remain Ask9,127

52Wk High76,200

52Wk Low36,900

52Wk Avg Vol9,522

Foreign Buy-

Frgn Owned(%)-

Dividend3,000

Dividend Yield0.04

Beta0.08

EPS7,839

P/E8.60

F P/E19.32

BVPS22,815

P/B2.95

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with DP3: BMP DHT FPT MKV VNM
Trending: HPG (83,828) - NVL (71,717) - DIG (66,436) - VND (61,486) - MBB (60,859)
1 day | 5 day | 3 months | 6 months | 12 months
- Central Phamarceutical Joint Stock Company No 3 (DP3), formerly known as Central Pharmaceutical Enterprise No.3 under the Ministry of Health, was established in 1962. The Company has its main business in manufacture and trade of pharmaceuticals, cosmetics, chemicals, and nutrient foods. The Company produces more than 100 types of medicines in which some types have asserted its position in domestic and international... View more
DateCloseChangeVolume
04/25/202467,300-100 (-0.15%)1,573
04/24/202467,400300 (+0.45%)2,604
04/23/202467,100-400 (-0.59%)11,100
04/22/202467,5000 (0.00%)1,335
04/19/202467,500-500 (-0.74%)10,853
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
03/21/2024DP3 Dividend payment in cash with 30.00% for 2023 (Record date)
03/21/2024DP3 Dividend payment in cash with 30.00% for 2023
07/11/2023DP3 Bonus share issue with 150.00%
03/21/2023DP3 Dividend payment in cash with 80.00% for 2022 (Record date)
03/21/2023DP3 Dividend payment in cash with 80.00% for 2022
04/24/2024Resolution of Annual Shareholders' Meeting 2024
04/23/2024FS Quarter 1 of 2024
04/03/20242024 Annual Shareholders’Meeting Documents
03/15/2024Annual report 2023
03/12/2024Audited FS 2023

Central Phamaceutical Joint Stock Company No3

Name: Central Phamaceutical Joint Stock Company No3

Abbreviation:FORIPHARM

Address: No.16 Le Dai Hanh Street, Minh Khai Ward Hong Bang Hai Phong

Telephone: (84.225) 384 2218

Fax: (84.225) 382 3125

Email:foripharm@hn.vnn.vn

Website:https://duocphamtw3.com

Exchange: HNX

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 07/17/2015

Chartered capital: 214,999,330,000

Listed shares: 21,499,933

Shares outstanding: 8,600,000

Status: Operating

Tax code: 0200572501

Establishment license:

Issued date: 09/15/2006

Business license: 0200572501

Issued date: 12/01/2003

Main business scope:

- Manufacturing and trading pharmaceutical products, cosmetics, chemicals, and nutrient food.

- Trading and processing pharmaceutical materials.

- 1962: Central Pharmaceutical Enterprise No.3 under the Ministry of Health was established;

- 2003: Transformed into Foripharm Central Pharmaceutical Joint Stock Company;

- 2006: Renamed as Central Pharmaceutical Joint Stock Company No 3 with an initial charter capital of VND7.5 billion;

- 2007: Increased the charter capital to VND25 billion;

- 2010: Increased the charter capital to VND35 billion;

- 2013: Increased the charter capital to VND52.5 billion;

- April 20, 2015: Listed on Hanoi Stock Exchange (HNX);

- July 17, 2015: Traded on Hanoi Stock Exchange (HNX);

- April 12, 2016: Increased the charter capital to VND68 billion;

- June 18, 2019: Increased the charter capital to VND86 billion;

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.